(Pediatric Research) Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease psychosis, agitation, and cognition? Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback